Tessera Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Tessera Therapeutics's estimated annual revenue is currently $65.9M per year.
- Tessera Therapeutics's estimated revenue per employee is $155,000
- Tessera Therapeutics's total funding is $431.8M.
- Tessera Therapeutics's current valuation is $1.7B. (April 2022)
Employee Data
- Tessera Therapeutics has 425 Employees.
- Tessera Therapeutics grew their employee count by -11% last year.
Tessera Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | General Counsel and Secretary | Reveal Email/Phone |
3 | SVP Finance and Corporate Controller | Reveal Email/Phone |
4 | SVP, Head Therapeutic Discovery and Translational Sciences | Reveal Email/Phone |
5 | SVP, Head Corporate Development | Reveal Email/Phone |
6 | VP, IP & Legal Affairs | Reveal Email/Phone |
7 | Head Pharmacology | Reveal Email/Phone |
8 | Head HRIS | Reveal Email/Phone |
9 | SVP, Technical Operations - CMC Development and Manufacturing | Reveal Email/Phone |
10 | VP, Investor Relations and Strategic Finance | Reveal Email/Phone |
Tessera Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Tessera Therapeutics?
Our mission is to cure disease by writing the code of life
keywords:N/A
$431.8M
Total Funding
425
Number of Employees
$65.9M
Revenue (est)
-11%
Employee Growth %
$1.7B
Valuation
N/A
Accelerator
Tessera Therapeutics News
2022-04-17 - Tessera Therapeutics Raises Over $300M in Series C Financing
Tessera Therapeutics, a Somerville, MA-based biotechnology company, raised over $300M in Series C funding.
2022-04-17 - Tessera Therapeutics stacks up more than $300M in series C funds ...
Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million...
2022-04-17 - Tessera Therapeutics Announces Over $300M Series C Financing ...
Tessera Therapeutics is pioneering GENE WRITING technology, which consists of multiple technology platforms designed to offer scientists and...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $173.1M | 426 | -3% | N/A |
#2 | $70.5M | 427 | -10% | $107.9M |
#3 | $74.3M | 428 | -7% | $52.6M |
#4 | $92.4M | 428 | -15% | $200M |
#5 | $47.3M | 429 | 5% | $520M |